When you grow up with a popular household brand and it disappears from the market, there is all the more reason to celebrate its comeback. That is what several of us did a few days ago when we came together to celebrate the return to the Philippine market of Eye Mo.
The Eye Mo brand was acquired from GlaxoSmithkline by Pharma Health Care Pte. Ltd (Singapore) in 2016. Pharma Health Care Pte. Ltd is part of the Combiphar Group of Companies, a leading multinational consumer healthcare company based in Indonesia. Established in 1971, Combiphar now manufactures and markets almost 200 prescription and over-the-counter (OTC) drugs, including Eye Mo. Combiphar is currently building a new sterile facility to further improve its manufacturing facilities.